Sum Lam

Summary

Affiliation: St. John's University
Country: USA

Publications

  1. ncbi request reprint Strontium ranelate for the management of osteoporosis
    Sum Lam
    Department of Clinical Pharmacy Practice, St John s University, Queens, New York, USA
    Consult Pharm 23:531-7. 2008
  2. doi request reprint Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY 11439, USA
    Cardiol Rev 18:213-7. 2010
  3. doi request reprint Linezolid-associated thrombocytopenia
    Sum Lam
    Department of Clinical Pharmacy Practice, St John s University, Queens, NY, USA
    Consult Pharm 27:504-8. 2012
  4. ncbi request reprint Vaccines for older adults
    Sum Lam
    St John s University College of Pharmacy and Allied Health Professions, Department of Clinical Pharmcy Practice, Queens, New York 11439, USA
    Consult Pharm 24:380-91. 2009
  5. doi request reprint Azilsartan: a newly approved angiotensin II receptor blocker
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY, USA
    Cardiol Rev 19:300-4. 2011
  6. ncbi request reprint Interferon-beta1b for the treatment of multiple sclerosis
    Sum Lam
    St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, St Albert s Hall Room 114, 8000 Utopia Parkway, Queens, New York, NY 11439, USA
    Expert Opin Drug Metab Toxicol 4:1111-7. 2008
  7. ncbi request reprint Aliskiren: an oral renin inhibitor for the treatment of hypertension
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 15:316-23. 2007
  8. pmc Pharmacologic management of overactive bladder
    Sum Lam
    St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, 8000 Utopia Parkway, St Albert Hall, Room 114, Queens, NY 11439 0001, USA
    Clin Interv Aging 2:337-45. 2007
  9. ncbi request reprint Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 15:154-61. 2007
  10. ncbi request reprint Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Pharmacotherapy 26:1169-74. 2006

Detail Information

Publications18

  1. ncbi request reprint Strontium ranelate for the management of osteoporosis
    Sum Lam
    Department of Clinical Pharmacy Practice, St John s University, Queens, New York, USA
    Consult Pharm 23:531-7. 2008
    ..To evaluate the role of strontium ranelate in the management of osteoporosis...
  2. doi request reprint Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY 11439, USA
    Cardiol Rev 18:213-7. 2010
    ..It is also an alternative therapy for patients who have contraindications or intolerability to other antidiabetic agents...
  3. doi request reprint Linezolid-associated thrombocytopenia
    Sum Lam
    Department of Clinical Pharmacy Practice, St John s University, Queens, NY, USA
    Consult Pharm 27:504-8. 2012
    ..Clinicians should be vigilant in monitoring platelet counts in elderly patients who are receiving linezolid, especially in those who are at risk for bleeds or who have end-stage renal disease...
  4. ncbi request reprint Vaccines for older adults
    Sum Lam
    St John s University College of Pharmacy and Allied Health Professions, Department of Clinical Pharmcy Practice, Queens, New York 11439, USA
    Consult Pharm 24:380-91. 2009
    ..To update senior care pharmacists with current recommendations on influenza, pneumococcal, zoster, and tetanus vaccines for older adults 65 years of age or older...
  5. doi request reprint Azilsartan: a newly approved angiotensin II receptor blocker
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY, USA
    Cardiol Rev 19:300-4. 2011
    ..It is also an option for those patients who have contraindications or cannot tolerate other antihypertensive agents, including dry cough induced by angiotensin-converting enzyme inhibitors...
  6. ncbi request reprint Interferon-beta1b for the treatment of multiple sclerosis
    Sum Lam
    St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, St Albert s Hall Room 114, 8000 Utopia Parkway, Queens, New York, NY 11439, USA
    Expert Opin Drug Metab Toxicol 4:1111-7. 2008
    ..Multiple sclerosis is a debilitating autoimmune disorder that causes disability in young adults...
  7. ncbi request reprint Aliskiren: an oral renin inhibitor for the treatment of hypertension
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 15:316-23. 2007
    ..It is also an option for those patients who have contraindications or intolerability to other antihypertensive agents, including dry cough induced by ACE inhibitors...
  8. pmc Pharmacologic management of overactive bladder
    Sum Lam
    St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, 8000 Utopia Parkway, St Albert Hall, Room 114, Queens, NY 11439 0001, USA
    Clin Interv Aging 2:337-45. 2007
    ..This article summarizes the efficacy, contraindications, precautions, dosing and common side effects of these agents. All available clinical trials on trospium, solifenacin and darifenacin were reviewed to determine its place in therapy...
  9. ncbi request reprint Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 15:154-61. 2007
    ..Overall, varenicline is a breakthrough in the management of tobacco addiction and has demonstrated good efficacy in motivated quitters. It also provides an option for smokers who cannot tolerate other pharmacologic interventions...
  10. ncbi request reprint Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Pharmacotherapy 26:1169-74. 2006
    ..Cefepime toxicity should be suspected whenever a patient receiving the drug experiences a change in mental status or myoclonus...
  11. ncbi request reprint Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 14:205-11. 2006
    ..It is also an alternative therapy for those patients who cannot tolerate other antidiabetic drugs...
  12. ncbi request reprint Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinic
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
    Am J Health Syst Pharm 62:626-9. 2005
  13. ncbi request reprint Sitagliptin: a novel drug for the treatment of type 2 diabetes
    Mary Choy
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 15:264-71. 2007
    ..It is also an alternative therapy for those patients who have contraindications or intolerability to other antidiabetic agents...
  14. doi request reprint Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolism
    TERRY CHEN
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, New York, USA
    Cardiol Rev 17:192-7. 2009
    ..It has the major advantages of once daily oral dosing and no required laboratory monitoring, giving it the potential to replace current antithrombotics in the market today...
  15. pmc Disease modifying agents for multiple sclerosis
    Olga Hilas
    St John s University College of Pharmacy and Allied Health Professions, Queens, NY, USA
    Open Neurol J 4:15-24. 2010
    ..To summarize major clinical trials which evaluate the efficacy and safety data of approved disease modifying agents for the treatment of various types of multiple sclerosis...
  16. doi request reprint Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Health Sciences, St John s University, Queens, NY 11439, USA
    Cardiol Rev 21:207-12. 2013
    ..Overall, apixaban is a safe and efficacious alternative for stroke prophylaxis in high-risk patients who have AF and who are unable to achieve therapeutic goals with warfarin therapy...
  17. doi request reprint Emerging therapies for the treatment of Helicobacter pylori infections
    Tomasz Z Jodlowski
    College of Pharmacy and Allied Health Professions, St John s University, 8000 Utopia Parkway, Queens, NY 11439, USA
    Ann Pharmacother 42:1621-39. 2008
    ..To describe emerging therapies, such as levofloxacin, moxifloxacin, rifabutin, rifaximin, tinidazole, doxycycline, minocycline, lactoferrin, and plaunotol for the eradication of Helicobacter pylori infection...
  18. ncbi request reprint Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus
    Sum Lam
    Geriatric Research, Education and Clinical Center GRECC, Veterans Affairs Medical Center, Durham, NC, USA
    Heart Dis 5:231-40. 2003
    ..In summary, insulin glargine offers a promising alternative as a once-daily basal insulin therapy in patients with type 1 and type 2 diabetes...